The Personal Touch: Ortho Implants Challenger Corin Creates Its Own Value Pathway
Mid-size orthopedic implants group Corin is back in the public eye after its recent purchase by a Permira-funded group. Now ready to embark on the next chapter of its development globally, it has a clear growth plan and a firm strategic line on both what it will and will not do as a business.
You may also be interested in...
Hip and knee replacement challenger firm Corin Group has a big ambition to revolutionize orthopedics with connected digital ecosystems and patient-specific concepts. That aim has come a step closer with its acquisition of robotic-assisted total knee replacement (TKR) company Omni Orthopaedics. Corin's Elvio Gramignano believes this approach will lead to real change in health care delivery.
Hip and knee replacement firm Corin Group is taking its digitally-connected ecosystem concept a stage further after agreeing to acquire US-based Omni Orthopaedics Inc., a pioneer in robotic-assisted total knee replacement. The transaction will be completed in the first half of March.
For hospitals, orthopedic capabilities might seem like an arms race – they do not want to be left behind the curve when rivals are tooling up. Patients may have positive views of the technology, even if data on clinical benefits is not yet available in great volumes. So says Jefferies Healthcare equity analyst Raj Denhoy, who believes it is not a done deal for health care robotics just yet.